Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1067361.RASpLlVNmYwSkpLjDrcGplsqk5H-JWMO1IXoBj9U2uZKg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1067361.RASpLlVNmYwSkpLjDrcGplsqk5H-JWMO1IXoBj9U2uZKg130_assertion type Assertion NP1067361.RASpLlVNmYwSkpLjDrcGplsqk5H-JWMO1IXoBj9U2uZKg130_head.
- NP1067361.RASpLlVNmYwSkpLjDrcGplsqk5H-JWMO1IXoBj9U2uZKg130_assertion description "[Therapy targeting Vav3 in combination with docetaxel may have practical implications for managing castration-resistant prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1067361.RASpLlVNmYwSkpLjDrcGplsqk5H-JWMO1IXoBj9U2uZKg130_provenance.
- NP1067361.RASpLlVNmYwSkpLjDrcGplsqk5H-JWMO1IXoBj9U2uZKg130_assertion evidence source_evidence_literature NP1067361.RASpLlVNmYwSkpLjDrcGplsqk5H-JWMO1IXoBj9U2uZKg130_provenance.
- NP1067361.RASpLlVNmYwSkpLjDrcGplsqk5H-JWMO1IXoBj9U2uZKg130_assertion SIO_000772 23566222 NP1067361.RASpLlVNmYwSkpLjDrcGplsqk5H-JWMO1IXoBj9U2uZKg130_provenance.
- NP1067361.RASpLlVNmYwSkpLjDrcGplsqk5H-JWMO1IXoBj9U2uZKg130_assertion wasDerivedFrom befree-2016 NP1067361.RASpLlVNmYwSkpLjDrcGplsqk5H-JWMO1IXoBj9U2uZKg130_provenance.
- NP1067361.RASpLlVNmYwSkpLjDrcGplsqk5H-JWMO1IXoBj9U2uZKg130_assertion wasGeneratedBy ECO_0000203 NP1067361.RASpLlVNmYwSkpLjDrcGplsqk5H-JWMO1IXoBj9U2uZKg130_provenance.